Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (1-(((5-methyl-2-oxooxazolidin-4-yl)carbonyl)-3-(thiazol-4-yl)alanyl)-2-methylpyrrolidine
1. Rovatirelin [inn]
2. Ravatirelin
3. 204386-76-5
4. 9dl0x410py
5. Kps-0373
6. S-0373
7. (4s,5s)-5-methyl-n-((2s)-1-((2r)-2-methylpyrrolidin-1-yl)-1-oxo-3-((1,3-thiazol-4-yl)methyl)propan-2-yl)-2-oxo-1,3-oxazolidine-4-carboxamide
8. 4-oxazolidinecarboxamide, 5-methyl-n-[(1s)-2-[(2r)-2-methyl-1-pyrrolidinyl]-2-oxo-1-(4-thiazolylmethyl)ethyl]-2-oxo-, (4s,5s)-
9. Ravatirelin [inn]
10. Unii-9dl0x410py
11. 4-oxazolidinecarboxamide, 5-methyl-n-((1s)-2-((2r)-2-methyl-1-pyrrolidinyl)-2-oxo-1-(4-thiazolylmethyl)ethyl)-2-oxo-, (4s,5s)-
12. Chembl4297622
13. Schembl14306794
14. Dtxsid90174385
15. Db15338
16. J3.663.192i
17. Q27272404
18. (1-(((5-methyl-2-oxooxazolidin-4-yl)carbonyl)-3-(thiazol-4-yl)alanyl)-2-methylpyrrolidine
19. (4s,5s)-5-methyl-n-[(2s)-1-[(2r)-2-methylpyrrolidin-1-yl]-1-oxo-3-(1,3-thiazol-4-yl)propan-2-yl]-2-oxo-1,3-oxazolidine-4-carboxamide
20. 4-oxazolidinecarboxamide, 5-methyl-n-(2-(2-methyl-1-pyrrolidinyl)-2-oxo-1-(4-thiazolylmethyl)ethyl)-2-oxo-, (4s-(4.alpha.(r*(s*)),5.alpha.))-
| Molecular Weight | 366.4 g/mol |
|---|---|
| Molecular Formula | C16H22N4O4S |
| XLogP3 | 1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 366.13617637 g/mol |
| Monoisotopic Mass | 366.13617637 g/mol |
| Topological Polar Surface Area | 129 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 546 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Rovatirelin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rovatirelin, including repackagers and relabelers. The FDA regulates Rovatirelin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rovatirelin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Rovatirelin supplier is an individual or a company that provides Rovatirelin active pharmaceutical ingredient (API) or Rovatirelin finished formulations upon request. The Rovatirelin suppliers may include Rovatirelin API manufacturers, exporters, distributors and traders.
Rovatirelin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rovatirelin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rovatirelin GMP manufacturer or Rovatirelin GMP API supplier for your needs.
A Rovatirelin CoA (Certificate of Analysis) is a formal document that attests to Rovatirelin's compliance with Rovatirelin specifications and serves as a tool for batch-level quality control.
Rovatirelin CoA mostly includes findings from lab analyses of a specific batch. For each Rovatirelin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rovatirelin may be tested according to a variety of international standards, such as European Pharmacopoeia (Rovatirelin EP), Rovatirelin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rovatirelin USP).
LOOKING FOR A SUPPLIER?
